News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,996 Results
Type
Article (14966)
Company Profile (299)
Press Release (267725)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80090)
Career Advice (163)
Deals (13369)
Drug Delivery (39)
Drug Development (50754)
Employer Resources (31)
FDA (5865)
Job Trends (5184)
News (145473)
Policy (10114)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (922)
Accelerated approval (19)
Adcomms (14)
Allergies (85)
Alliances (21823)
ALS (127)
Alzheimer's disease (1036)
Antibody-drug conjugate (ADC) (243)
Approvals (6064)
Artificial intelligence (267)
Autoimmune disease (119)
Automation (9)
Bankruptcy (105)
Best Places to Work (4574)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (46)
Breast cancer (347)
Cancer (3168)
Cardiovascular disease (239)
Career advice (148)
Career pathing (8)
CAR-T (222)
CDC (5)
Cell therapy (576)
Cervical cancer (14)
Clinical research (43762)
Collaboration (1169)
Company closure (2)
Compensation (603)
Complete response letters (41)
COVID-19 (1106)
CRISPR (87)
C-suite (566)
Cystic fibrosis (114)
Data (4369)
Denatured (15)
Depression (93)
Diabetes (256)
Diagnostics (1384)
Digital health (13)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (196)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (218)
Earnings (31799)
Editorial (26)
Employer branding (4)
Employer resources (29)
Events (51894)
Executive appointments (629)
FDA (7636)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (993)
Gene editing (186)
Generative AI (22)
Gene therapy (497)
GLP-1 (507)
Government (1159)
Grass and pollen (3)
Guidances (166)
Healthcare (6624)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (194)
Immuno-oncology (43)
Indications (71)
Infectious disease (1216)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (169)
Interviews (18)
IPO (7353)
IRA (13)
Job creations (869)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (23)
Layoffs (244)
Leadership (10)
Legal (1403)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (251)
Machine learning (24)
Management (7)
Manufacturing (379)
MASH (132)
Medical device (2672)
Medtech (2681)
Mergers & acquisitions (6649)
Metabolic disorders (733)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (233)
Neuropsychiatric disorders (70)
Neuroscience (1965)
Neurotech (1)
NextGen: Class of 2026 (2039)
Non-profit (868)
Now hiring (31)
Obesity (333)
Opinion (125)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (165)
Parkinson's disease (232)
Partnered (12)
Patents (307)
Patient recruitment (343)
Peanut (44)
People (26742)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15509)
Phase 2 (20334)
Phase 3 (12841)
Pipeline (3354)
Policy (91)
Postmarket research (854)
Preclinical (6552)
Press Release (30)
Prostate cancer (148)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (666)
Real estate (1467)
Recruiting (12)
Regulatory (9956)
Reports (19)
Research institute (974)
Resumes & cover letters (19)
Rett syndrome (25)
RNA editing (21)
RSV (17)
Schizophrenia (124)
Series A (184)
Series B (140)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2008)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (340)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Today (95)
Last 7 days (318)
Last 30 days (1183)
Last 365 days (17930)
2026 (1946)
2025 (18139)
2024 (20594)
2023 (22460)
2022 (26851)
2021 (27828)
2020 (23410)
2019 (16268)
2018 (11778)
2017 (13781)
2016 (11907)
2015 (14395)
2014 (10454)
2013 (7541)
2012 (7618)
2011 (7686)
2010 (7499)
Location
Africa (157)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18466)
Australia (3119)
California (7140)
Canada (1858)
China (781)
Colorado (249)
Connecticut (256)
Delaware (236)
Europe (39330)
Florida (912)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (398)
India (36)
Indiana (162)
Iowa (8)
Japan (233)
Kansas (80)
Kentucky (10)
Louisiana (7)
Maine (11)
Maryland (742)
Massachusetts (5642)
Michigan (110)
Minnesota (251)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1702)
New Mexico (13)
New York (1776)
North Carolina (836)
North Dakota (6)
Northern California (3516)
Ohio (179)
Oklahoma (11)
Oregon (24)
Pennsylvania (1287)
Puerto Rico (9)
Rhode Island (25)
South America (223)
South Carolina (9)
Southern California (2830)
Tennessee (40)
Texas (918)
United States (23591)
Utah (97)
Virginia (137)
Washington D.C. (37)
Washington State (593)
West Virginia (1)
Wisconsin (46)
282,996 Results for "cargo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since the January decision to halt its lead candidate for a certain type of aggressive large B cell lymphoma.
July 8, 2025
·
1 min read
·
Annalee Armstrong
Layoffs
Cargo Halts CAR T Trial, Lays Off 50% of Workforce in Pipeline Reset
CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.
January 30, 2025
·
2 min read
·
Heather McKenzie
Press Releases
CARGO Therapeutics Provides Corporate Update
March 18, 2025
·
4 min read
Press Releases
Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein Cargo to the Brain
October 1, 2025
·
1 min read
Biotech Bay
CARGO Therapeutics to Participate in Upcoming Investor Conferences - May 28, 2024
CARGO Therapeutics, Inc., a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, announced that the company will be participating in the following investor conferences.
May 28, 2024
·
2 min read
Biotech Bay
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
CARGO Therapeutics, Inc. announced that it has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of approximately $110.0 million, before deducting placement agent fees and other expenses.
May 28, 2024
·
5 min read
Press Releases
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
January 10, 2025
·
11 min read
Business
CARGO Therapeutics Announces Scientific Advisory Board
CARGO Therapeutics, Inc. today announced the formation of a Scientific Advisory Board (SAB) comprised of distinguished experts in cancer research, immunology, and CAR T-cell therapy.
December 6, 2023
·
4 min read
Press Releases
JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
July 16, 2025
·
7 min read
Genetown
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting.
May 9, 2024
·
3 min read
1 of 28,300
Next
